Product

MVA-SARS-2-S

1 clinical trial

1 indication

Indication

Clinical trial

A Multi-center, Randomized Placebo-controlled Phase II Trial to Assess the Safety, Tolerability and Immunogenicity of Two Doses of the Candidate Vaccine MVA-SARS-2-S in Adults Aged 18 to 64 and 65 and Older

Status: Withdrawn, Estimated PCD: 2022-11-02